249 related articles for article (PubMed ID: 30663827)
1. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
Ozanne EM; Howe R; Mallinson D; Esserman L; Van't Veer LJ; Kaplan CP
J Genet Couns; 2019 Jun; 28(3):507-515. PubMed ID: 30663827
[TBL] [Abstract][Full Text] [Related]
2. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
[TBL] [Abstract][Full Text] [Related]
3. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly MB; Pilarski R; Axilbund JE; Berry M; Buys SS; Crawford B; Farmer M; Friedman S; Garber JE; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Rana H; Reiser G; Robson ME; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wick MJ; Wiesner GL; Dwyer M; Kumar R; Darlow S
J Natl Compr Canc Netw; 2016 Feb; 14(2):153-62. PubMed ID: 26850485
[TBL] [Abstract][Full Text] [Related]
4. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
5. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
6. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
8. Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.
Hibler EA; Fought AJ; Kershaw KN; Molsberry R; Nowakowski V; Lindner D
J Med Internet Res; 2022 Feb; 24(2):e29124. PubMed ID: 35200148
[TBL] [Abstract][Full Text] [Related]
9. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
Kotnik U; Peterlin B; Lovrecic L
BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
[TBL] [Abstract][Full Text] [Related]
10. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
11. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
[TBL] [Abstract][Full Text] [Related]
12. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
14. Implementing a Population-Based Breast Cancer Risk Assessment Program.
Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
[TBL] [Abstract][Full Text] [Related]
15. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
16. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
17. Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
Joseph G; Kaplan C; Luce J; Lee R; Stewart S; Guerra C; Pasick R
Public Health Genomics; 2012; 15(3-4):172-80. PubMed ID: 22488460
[TBL] [Abstract][Full Text] [Related]
18. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
Nippert I; Schlegelberger B;
Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
[TBL] [Abstract][Full Text] [Related]
19. In the wake of Angelina - managing a family history of breast cancer.
Dunlop K; Kirk J; Tucker K
Aust Fam Physician; 2014; 43(1):76-8. PubMed ID: 24563902
[TBL] [Abstract][Full Text] [Related]
20. Population-based genetic testing for Women's cancer prevention.
Evans O; Gaba F; Manchanda R
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():139-153. PubMed ID: 32245629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
